ABSTRACT OBJECTIVES This study hypothesized that shielded electrodes could capture myocardium without extracardiac stimulation.
C ardiac resynchronization therapy (CRT) results in a significant reduction in mortality and symptoms in selected patients with heart failure (1). However, challenges remain with current approaches to resynchronization, including a high rate of non-responders due in part to anatomical limitations in negotiating the coronary venous system, resulting in suboptimal lead placement, phrenic stimulation precluding therapy delivery, and the risks and challenges associated with endovascular lead placement in specific patients such as those with congenital heart disease and patent foramen ovale (2, 3) . The alternative is the use of epicardial leads placed directly onto the left ventricle. However, this method currently requires a surgical approach, and there may need to be multiple revisions over time as these leads have an increased failure rate in long-term follow-up (4) . With 2% of the adult population in the developed world currently suffering from heart failure, a rising prevalence as longevity increases, and an estimated 5% to 10% of heart failure patients having an indication for CRT (5) , there is an increasing role for more versatile pacing approaches to help overcome some of these limitations.
The technique for percutaneous subxiphoid access to the pericardial space, initially described by Sosa et al. (6) for the purpose of epicardial mapping of ventricular tachycardia, lends itself well to epicardial pacing, as much of the cardiac surface is reachable through the anterior approach (7, 8) . However, the phrenic nerves are also intimately related, and pacing in the pericardial space risks inadvertent phrenic capture.
We developed percutaneously delivered leads with multiple electrodes arranged in a forked configuration ( Figure 1 ), allowing for multiple pacing vectors over a wide area of myocardium. We hypothesized that use of selective insulation on the pericardialfacing aspect of the lead would direct the electric field toward cardiac tissue, permitting pacing without extracardiac stimulation and defibrillation without pain. The purpose of this initial study was to confirm that these self-expanding novel leads could be placed percutaneously in the pericardial space and thus could selectively pace myocardium while avoiding extracardiac stimulation, regardless of their position.
METHODS
LEAD DESIGN AND PROTOTYPING. The novel partially insulated multi-electrode lead was designed to be introduced percutaneously into the pericardial cavity and permit multiple pacing vectors to be applied over a variably wide epicardial surface area.
This was accomplished through use of an expanding design, which could be introduced into a sheath in a low-profile state and then expanded once deployed in the pericardium to permit pacing and sensing from desired regions (Figures 1 to 3 ). Electrodes were selectively insulated to direct the electric field toward the myocardium and shaped to a convexity closely representing that of the epicardial surface to maximize contact.
The prototype lead has a 50-cm long, 16-F central body containing a central 8F channel (Online Figure 1 ) and is wire in nylon insulation. The distal end of the device has a forked design, with two arms 5.4 cm long and 1.5 mm in diameter and curved to a convexity similar to that of the epicardial surface.
Each arm hosts 3 to 4 stainless steel circumferential electrodes placed 7 mm apart and covered circumferentially by polyether block amide insulation (Pebax, Arkema, King-of-Prussia, Pennsylvania) on all sides, except at the exposed surface (3.2 Â 1.5 mm) intended to be placed onto the epicardium.
The lead is deployable in the pericardial space through a percutaneously introduced steerable sheath ( Figure 2) . The sheath has a round caliber measuring 24-F in external diameter, with a 20-F central channel sealed with a one-way valve. In certain prototype iterations, it is designed with distal mapping electrodes and a detachable proximal handle to enable it to function as a platform that directs therapies toward the myocardium and enable (Middle left) Prototype iteration that has a single nitinol loop for lead arm stability. (Middle right) Prototype iteration that incorporates a second nitinol loop to harness the pericardium for additional support, which in this iteration, also houses 3 additional insulated electrodes.
(Bottom) En face profile demonstrates dimensions in inches (millimeters in parentheses). See Online Video 3.
PERCUTANEOUS PERICARDIAL ACCESS. Percutaneous pericardial access of the anterior surface of the heart was obtained using the technique described by Sosa (6) and, upon progressive dilatation of the access site with serially larger diameter dilators, 1 to 2 of the prototype steerable sheaths were deployed in the pericardial space. Pneumopericardium and pericardial effusions were monitored for using ICE and fluoroscopy and controlled using pericardial aspiration from the sheath. The novel leads were introduced into the sheath, which Using side-by-side fluoroscopic images to ensure comparable catheter location, leads were rotated such that the electrodes were turned from facing the heart Syed et al.
to facing the serosal surface of the parietal pericardium, and the above-described protocol was repeated to generate paired sensing and pacing data. We designed our leads to harness the pericardium for mechanical support, introduced supportive nitinol loops to provide additional lead and lead arm stability, and contoured the lead to the natural curvature of the cardiac surface. These actions together resulted in good lead stability and function at the areas of interest. A combination of fluoroscopic and electrical navigation was sufficient for accurate placement, and ICE was used to monitor for complications to chambers, valves, and pericardium. The use of steerable sheaths greatly facilitated maneuverability of leads, and the successful use of this strategy for epicardial ablation has been previously reported (12) . We investigated whether our data were influenced by differences in interelectrode distances between the parallel bipolar configuration, with the more distal electrode pair being farther apart than Syed et al. (Figures 1 and 3 ) and were not able to demonstrate this. We did find, however, that, owing to the size and shape of the forked design, the distal-most pair had a higher threshold, most likely due to interaction with the valvular annuli and great vessels and over corners that needed to be negotiated, a finding which is being incorporated into designing the next prototypes for chronic, indwelling use.
Because of the course of the phrenic nerves in intimate proximity to the pericardium (13) (14, 15) , requiring either repositioning the lead or electrically reprogramming another vector, both of which may result in lead dysfunction (16, 17) .
Detecting phrenic stimulation at implantation has poor sensitivity due to positional dependency (18) calling for alternative strategies for preventing stimulation. We demonstrated that our insulated lead has differential sensing and pacing function depending on the side insulated, resulting in a significant threshold margin between myocardial and extracardiac stimulation. In clinical studies, a threshold difference <3 V has been associated with clinically significant phrenic stimulation (19) . Other strategies that have been reported include using leads with multiple electrodes, allowing for reprogramming between electrodes (20), using closely spaced bipoles (21) , and having longer pulse duration (22), although we did not attempt to replicate these findings for epicardial pacing or investigate whether they have incremental effect.
In clinical practice, resynchronization therapy fails for 25% to 40% of patients (23) (24) (25) . An important mechanism for failure to response may be absence of pacing at a late electrically activated site (26) (27) (28) 
